Cordlife Group Limited

Equities

P8A

SG2E64980112

Healthcare Facilities & Services

Delayed Singapore S.E. 04:01:53 2024-05-24 am EDT 5-day change 1st Jan Change
0.153 SGD +4.08% Intraday chart for Cordlife Group Limited +2.00% -51.43%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Cordlife Group Limited Announces Changes to the Composition of Board and the Board Composition CI
Cordlife Group Limited Announces Change of Company Secretaries CI
Cordlife Scraps Proposed SG$8 Million Capital Raise After Court Upholds Injunction MT
Cordlife Granted Further Waiver to Publish Sustainability Report MT
Cordlife Customers Reportedly Tap Singapore Law Firm in Cryogenic Storage Case MT
Cordlife Director Released on Bail Amid Cryogenic Storage Probe MT
Cordlife Applies for Further Waver to Issue 2023 Sustainability Report MT
Cordlife Group Limited Announces Retirement of Cheong Tuck Yan Titus Jim as Independent Director CI
Cordlife Group Limited Announces the Appointment of Xu, Tianhong as Independent Non-Executive Director, Effective May 14, 2024 CI
Cordlife Group Limited Announces the Appointment of Dato' Dr. Teo Tong Kooi as Independent Non-Executive Director, Effective May 14, 2024 CI
Cordlife Group Limited Announces the Appointment of Cai, Yong as Independent Non-Executive Director, Effective May 14, 2024 CI
Cordlife Group Limited Announces Directors Removal CI
Cordlife Group Looking for More Independent Directors Amid Cryogenic Tank Issues MT
Cordlife Receives Letter of Demand for Alleged Breach of Service Agreement MT
Cordlife Group Limited Announces Retirement of Joseph Wong Wai Leung as Independent Non-Executive Director, Member of the Audit and Risk Committee, Member of the Remuneration Committee CI
Cordlife Group Lodges Police Report Against Former Staff Over Cryogenic Tank Incident MT
Cordlife Enters Subscription Agreements MT
Cordlife Granted Extension of Time to Hold AGM MT
Cordlife Applies For Extension to Annual General Meeting and Financial Reporting MT
Cordlife To Remain Under a Trading Halt MT
Cordlife’s CFO Released on Bail MT
Cordlife Receives Singapore Government Order to Provide Information Amid Cryogenic Tank Probe MT
Cordlife Remains Under Trading Halt MT
Singapore Stocks End Week in Red; Pacific Century Shares Surge 9% Despite Swinging to H2 2023 Loss MT
Cordlife Group’s Attributable Profit Halves as Company Battles Legal Issues; Shares Slump 9% MT
Chart Cordlife Group Limited
More charts
Cordlife Group Limited is a Singapore-based company that owns cord blood banks in Asia with full stem cell banking facilities in Singapore, Hong Kong, Indonesia, the Philippines, India and Malaysia. The Company’s segments include Banking and Diagnostics. The banking segment comprises the collection, processing and banking of biological materials. The diagnostics segment comprises diagnostics testing services. Its banking services include cord blood, cord lining, cord lining mesenchymal stem cells, corneal lenticule, cord lining epithelial stem cells, cord tissue and others. Its diagnostic testing services include newborn genetic screening, pediatric vision screening, pediatric ear screening, pediatric allergen test, genetic talent test, preimplantation genetic screening, endometrial receptivity test, non-invasive prenatal testing and newborn metabolic screening. Its MOMS UP is a mobile app offering pregnancy, as well as parenting resources for moms and moms-to-be in Asia.
More about the company
  1. Stock Market
  2. Equities
  3. P8A Stock
  4. News Cordlife Group Limited
  5. Cordlife Group Ordered by Health Ministry to Stop Sample Collection for Six Months